These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 13336211)

  • 21. [Retardation of elimination of paraminosalicylic acid by benemid].
    WILHELMI E; SANZ MC
    Schweiz Z Tuberk; 1952; 9(4):296-305. PubMed ID: 14958399
    [No Abstract]   [Full Text] [Related]  

  • 22. [Calcium excretion in therapy with antituberculotic drugs].
    LANYI RM
    Z Tuberk; 1952; 101(3-4):190-2. PubMed ID: 13039456
    [No Abstract]   [Full Text] [Related]  

  • 23. [Absorption and excretion of drugs. XI. Separatory determination of the urinary metabolites of p-aminosalicylic acid in man].
    KAKEMI K; ARITA T; YAMASHINA H; KONISHI R
    Yakugaku Zasshi; 1962 Apr; 82():540-2. PubMed ID: 14453192
    [No Abstract]   [Full Text] [Related]  

  • 24. The spectrophotometric determination of para-aminosalicylic acid and its acetyl derivative in human urine.
    CHARNEY J; KUNA M
    Am Rev Tuberc; 1951 Nov; 64(5):577-8. PubMed ID: 14885690
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental studies on intrapleural absorption of p-aminosalicylic acid].
    SCHWEIGER O; TOMCSANYI A; KULKA F; LEHOCKI M; TOMCSANYI A
    Acta Physiol Acad Sci Hung; 1957; 11(1):83-94. PubMed ID: 13424311
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in resorption of oral administered p-aminosalicylic acid by hyaluronidase].
    MAUER H; KLEIN H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 109(6):478-81. PubMed ID: 13126060
    [No Abstract]   [Full Text] [Related]  

  • 27. [Contribution to the study of the metabolism of para-aminosalicylic acid. I. Determination methods].
    DESBORDES J; BORY J; GUYOT-JEANNIN C
    Bull Soc Chim Biol (Paris); 1951; 33(1-2):179-87. PubMed ID: 14935582
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of probenecid (benemid) in enhancing para-aminosalicylic acid concentrations in the blood.
    BREITENBUCHER RB; AMATUZIO DS; FALK A
    Am Rev Tuberc; 1952 Aug; 66(2):228-32. PubMed ID: 14943930
    [No Abstract]   [Full Text] [Related]  

  • 29. [Behavior of blood concentration and elimination in the urine of p-aminosalicylic acid after administration of substances with retarding action; experimental and clinical research].
    BERTOLANI F
    Rass Fisiopatol Clin Ter; 1950; 22(1-2):41-62. PubMed ID: 15441150
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inhibition of PAS elimination by sulfalkylamides of benzoic acid].
    OSTERLOH G
    Dtsch Gesundheitsw; 1953 Apr; 8(14):413-7. PubMed ID: 13067773
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aldehyde reaction in the urine during PAS therapy].
    LENT W
    Med Klin; 1950 Aug; 45(34):1059. PubMed ID: 14779804
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gerhardt's test and PAS].
    LEBON J; FOURRIER A; GALLEY P
    Alger Medicale; 1955 Aug; 59(8):507. PubMed ID: 13275441
    [No Abstract]   [Full Text] [Related]  

  • 33. Tebamin: a derivative of p-aminosalicylic acid; blood levels, absorption and excretion following oral administration.
    FREDERIKSEN E; JENSEN KA; MORCH P; TYBRING L
    Acta Pharmacol Toxicol (Copenh); 1957; 14(1):58-66. PubMed ID: 13469430
    [No Abstract]   [Full Text] [Related]  

  • 34. [Glycosuria and hyperglycemia due to PAS; clinical contribution].
    TEMPINI L
    G Ital Della Tuberc; 1951; 5(1):48-54. PubMed ID: 14823395
    [No Abstract]   [Full Text] [Related]  

  • 35. [Appearance of a reducing property in the urine of tuberculotics during PAS therapy].
    MARIANI B; MESCOLINI G
    Lotta Tuberc; 1951; 21(3-4):121-34. PubMed ID: 14851812
    [No Abstract]   [Full Text] [Related]  

  • 36. [A method for determination of the reducing power of urine after oral administration of PAS, as well as PAS metabolism in man].
    MEYER ZU SCHWABEDISSEN O; ZIMMERMANN J
    Klin Wochenschr; 1953 Jan; 31(3-4):87-90. PubMed ID: 13062581
    [No Abstract]   [Full Text] [Related]  

  • 37. [Increase of penicillin and PAS blood levels through excretion inhibitory substances (carinamide and benamide)].
    MATIS P; GROSS R; HEBEL R; HERTEL H
    Med Welt (Stuttg); 1951 Sep; 20(37):1135-9. PubMed ID: 14890498
    [No Abstract]   [Full Text] [Related]  

  • 38. A procedure for the determination of 4-aminosalicylic acid (p-aminosalicylic acid) in blood and in urine.
    TENNENT DM; LELAND ML
    J Biol Chem; 1949 Feb; 177(2):873-81. PubMed ID: 18123816
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies with C14 labeled para-aminosalicylic acid and isoniazid.
    EBERT RH; HELLER A; KOCH-WESER D; ROTH LJ
    Am Rev Tuberc; 1957 Jan; 75(1):71-82. PubMed ID: 13394864
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the metabolism of PAS. V. With special reference to the relation between the blood and urine sugar levels and PAS-glycosuria during insulin administration].
    TAKAHASHI H
    Yokohama Med Bull; 1961 Aug; 12():160-2. PubMed ID: 13919043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.